EDA2R and neoplasm: Our recent work demonstrated that ectodysplasin A2 (EDA‐A2) receptor (EDA2R) signalling mediates tumour‐induced muscle wasting by enhancing the expression of muscle atrophy‐related genes, including Atrogin1 and MuRF1.5